| scholarly article | Q13442814 |
| P50 | author | Jeremy M. Kahn | Q54165870 |
| Amber E Barnato | Q63021050 | ||
| P2093 | author name string | Bruce L Jacobs | |
| Chung-Chou H Chang | |||
| Justin E Bekelman | |||
| Florian R Schroeck | |||
| Joel B Nelson | |||
| Dwight E Heron | |||
| Samia H Lopa | |||
| Jonathan G Yabes | |||
| P2860 | cites work | Impact of hospital market competition on endovascular aneurysm repair adoption and outcomes | Q28290883 |
| Fitting Linear Mixed-Effects Models Using lme4 | Q30477923 | ||
| Development of a comorbidity index using physician claims data | Q30623996 | ||
| Small Area Variations in Health Care Delivery | Q34218094 | ||
| Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project. | Q35602667 | ||
| Physician social networks and variation in prostate cancer treatment in three cities. | Q35672812 | ||
| Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse | Q36406313 | ||
| Local coverage determination policy and the use of stereotactic body radiation therapy for prostate cancer | Q37143037 | ||
| Technology diffusion and diagnostic testing for prostate cancer | Q37308641 | ||
| Use of advanced treatment technologies among men at low risk of dying from prostate cancer. | Q37378693 | ||
| Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity | Q37702326 | ||
| Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. | Q37719072 | ||
| A Review of the Clinical Evidence for Intensity-modulated Radiotherapy | Q37776778 | ||
| Stereotactic body radiation therapy: scope of the literature | Q37871237 | ||
| Utilization of anesthesia services during outpatient endoscopies and colonoscopies and associated spending in 2003-2009. | Q37995832 | ||
| Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer. | Q39736576 | ||
| Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012. | Q39772182 | ||
| Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes | Q41775778 | ||
| Urologists' use of intensity-modulated radiation therapy for prostate cancer | Q46849076 | ||
| Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. | Q55041226 | ||
| Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer | Q62514147 | ||
| Personal, organizational, and market level influences on physicians' practice patterns: results of a national survey of primary care physicians | Q74251675 | ||
| Fractionation and protraction for radiotherapy of prostate carcinoma | Q77227878 | ||
| Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer | Q80070384 | ||
| Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity | Q82264151 | ||
| Implications of Market Competition, Technology Adoption, and Cost for Surgical Patients | Q87311633 | ||
| P4510 | describes a project that uses | ggplot2 | Q326489 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2945-2954 | |
| P577 | publication date | 2017-03-16 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer | |
| P478 | volume | 123 |
| Q91171198 | Patterns of stereotactic body radiation therapy: The influence of lung cancer treatment on prostate cancer treatment |
| Q99708289 | Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States |
| Q46084626 | Travel distance and stereotactic body radiotherapy for localized prostate cancer |
Search more.